Background: Palm and sole skin eruptions have a broad differential diagnosis. It is particularly important to recognize common causes as well as their association with certain chemotherapy regimens such as Capecitabine. Case report: A 79-year-old woman presented with a painful rash on her hands and feet for 1 week. She had metastatic colon cancer and was in her third week of treatment with capecitabine. Her diagnosis was a medication side-effect from chemotherapy. Capecitabine was stopped and she had some clinical improvement over the next two days. She was discharged with oncology follow up for resumption of Capecitabine at a lower dose with improvement in her rash 3 weeks later. Discussion: Skin rashes are a commonly encountered complain...
A59-year-old woman with advanced rec-tal cancer underwent a 2-week courseof chemotherapy with capeci...
Introduction: Dermatology complaints account for 3.3% of emergency department (ED) visits per year. ...
Aims: To identify pre-treatment risk factors for the development of Palmar Plantar Erythrodysesthesi...
Laila Tsaqilah,1 Keshia Amalia Mivina Mudia,1 Hermin Aminah Usman,2 Hartati Purbo Dharmadji,1 Risa M...
Capecitabine is a 5-fluorouracil basedchemotherapeutic drug widely used in the treatmentof solid tum...
To the Editor: Capecitabine is a chemotherapeutic agent of the fluoropyrimidine family, indicated in...
Palmar-Plantar Erythrodysesthesia (PPE) (or) Burgdorf’s Reaction (BR) (or) Hand-Foot Syndrome (HFS) ...
Background: Dermatoses affecting the palms and soles are more common in our day-to-day practice, bec...
Capecitabine is an oral chemotherapeutic agent that is converted to 5-fluorouracil (5-FU) by thymidi...
Abstract. Introduction. Acral erythema, also known as palmoplantar erythrodysesthesia or hand-foot s...
We report a case of a 62 year-old patient who developed Palmar-plantar erythrodysesthesia upon recei...
BACKGROUND: Many cytotoxic and biological drugs are cause of severe dermatological side effects, su...
BACKGROUND: Palmoplantar dermatoses often show therapeutic problem. PUVA therapy represents an effe...
Background: COVID-19 is a pandemic disease that has no definite treatment or preventive medication u...
Introduction: Adverse reactions to medications often present with involvement of the integument. The...
A59-year-old woman with advanced rec-tal cancer underwent a 2-week courseof chemotherapy with capeci...
Introduction: Dermatology complaints account for 3.3% of emergency department (ED) visits per year. ...
Aims: To identify pre-treatment risk factors for the development of Palmar Plantar Erythrodysesthesi...
Laila Tsaqilah,1 Keshia Amalia Mivina Mudia,1 Hermin Aminah Usman,2 Hartati Purbo Dharmadji,1 Risa M...
Capecitabine is a 5-fluorouracil basedchemotherapeutic drug widely used in the treatmentof solid tum...
To the Editor: Capecitabine is a chemotherapeutic agent of the fluoropyrimidine family, indicated in...
Palmar-Plantar Erythrodysesthesia (PPE) (or) Burgdorf’s Reaction (BR) (or) Hand-Foot Syndrome (HFS) ...
Background: Dermatoses affecting the palms and soles are more common in our day-to-day practice, bec...
Capecitabine is an oral chemotherapeutic agent that is converted to 5-fluorouracil (5-FU) by thymidi...
Abstract. Introduction. Acral erythema, also known as palmoplantar erythrodysesthesia or hand-foot s...
We report a case of a 62 year-old patient who developed Palmar-plantar erythrodysesthesia upon recei...
BACKGROUND: Many cytotoxic and biological drugs are cause of severe dermatological side effects, su...
BACKGROUND: Palmoplantar dermatoses often show therapeutic problem. PUVA therapy represents an effe...
Background: COVID-19 is a pandemic disease that has no definite treatment or preventive medication u...
Introduction: Adverse reactions to medications often present with involvement of the integument. The...
A59-year-old woman with advanced rec-tal cancer underwent a 2-week courseof chemotherapy with capeci...
Introduction: Dermatology complaints account for 3.3% of emergency department (ED) visits per year. ...
Aims: To identify pre-treatment risk factors for the development of Palmar Plantar Erythrodysesthesi...